Rezolute Files 8-K: Regulation FD Disclosure Signals New Info
Ticker: RZLT · Form: 8-K · Filed: Mar 24, 2026 · CIK: 0001509261
| Field | Detail |
|---|---|
| Company | Rezolute, Inc. (RZLT) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulation-fd, disclosure, corporate-action
TL;DR
**Rezolute just dropped an 8-K with new info, watch for details in Exhibit 99.1.**
AI Summary
Rezolute, Inc. filed an 8-K on March 24, 2026, under Regulation FD Disclosure, indicating they are sharing new, material non-public information. This filing includes an exhibit, EX-99.1, which likely contains the details of this disclosure. For investors, this matters because new information, especially if it's significant, could impact the company's stock price, potentially signaling new developments in their pharmaceutical preparations business.
Why It Matters
This filing signals that Rezolute, Inc. is releasing new, potentially market-moving information, which could affect investor perception and stock valuation.
Risk Assessment
Risk Level: medium — The risk is medium because the content of the disclosure (EX-99.1) is not yet known, but Regulation FD disclosures often contain material information that can move the stock.
Analyst Insight
A smart investor would immediately review Exhibit 99.1 to understand the specific material information Rezolute, Inc. is disclosing, as this could significantly impact the stock's short-term performance.
Key Numbers
- 2026-03-24 — Filing Date (The date the 8-K was filed and accepted by the SEC.)
- 001-39683 — File Number (The SEC file number for Rezolute, Inc.)
Key Players & Entities
- Rezolute, Inc. (company) — the filer of the 8-K
- 0001509261 (company) — CIK of Rezolute, Inc.
- 2026-03-24 (date) — filing date and period of report
- Item 7.01 (person) — Regulation FD Disclosure item
- Item 9.01 (person) — Financial Statements and Exhibits item
FAQ
What is the primary purpose of Rezolute, Inc.'s 8-K filing on March 24, 2026?
The primary purpose of Rezolute, Inc.'s 8-K filing on March 24, 2026, is to disclose information under Item 7.01, Regulation FD Disclosure, indicating the company is making a public disclosure of material non-public information.
Where can investors find the detailed information referenced in this 8-K filing?
Investors can find the detailed information referenced in this 8-K filing in Exhibit 99.1, which is listed as 'EXHIBIT 99.1 tm269642d1_ex99-1.htm' within the filing documents.
Filing Stats: 694 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2026-03-24 07:30:12
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share RZLT Nasdaq Capital Market
Filing Documents
- tm269642d1_8k.htm (8-K) — 29KB
- tm269642d1_ex99-1.htm (EX-99.1) — 19KB
- 0001104659-26-033592.txt ( ) — 217KB
- rzlt-20260324.xsd (EX-101.SCH) — 3KB
- rzlt-20260324_lab.xml (EX-101.LAB) — 33KB
- rzlt-20260324_pre.xml (EX-101.PRE) — 22KB
- tm269642d1_8k_htm.xml (XML) — 3KB
01
Item 7.01 Regulation FD Disclosure. On March 24, 2026, Rezolute, Inc. (the "Company") issued a press release to announce results from its recent meeting with the FDA. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K. The poster contains forward looking statements. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "prove," "potential," "seek," "strive," "try," or future or conditional verbs such as "predict," "could," "may," "likely," "should," "will," "would," or similar expressions. The Company's ability to predict results or the actual results of the Company's plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers of the poster are cautioned not to place undue reliance on these forward-looking cause such a difference include any other factors discussed in the Company's filings with the SEC, including the Risk Factors contained in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available at the SEC
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press Release, dated March 24, 2026 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REZOLUTE, INC. DATE: March 24, 2026 By: /s/ Nevan Charles Elam Nevan Charles Elam Chief Executive Officer